Q2 FY2026 · ended Jun 30, 2026 · Revenue $8.53M, -14.3% YoY · Filed Aug 12, 2026
Utah Medical Products, Inc. (UTMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $8.5 million and net income of $2.7 million. Free cash flow was $1.2 million. As of Jun 30, 2026 it held $87.5 million in cash and investments and $195,000 in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- UTMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Midvale, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 706698
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $8.5M | $8.7M | $9.0M | $9.8M | $10.0M |
| Operating income | $2.6M | $2.6M | $2.4M | $2.6M | $3.2M |
| Net income | $2.7M | $2.6M | $2.6M | $2.6M | $3.0M |
| Diluted EPS | $0.84 | $0.82 | $0.80 | $0.82 | $0.94 |
| Operating cash flow | $1.4M | $3.1M | $3.5M | $3.9M | $2.9M |
| Free cash flow | $1.2M | $3.0M | $3.4M | $3.9M | $2.8M |
| Total assets | $124.6M | $124.4M | $122.5M | $122.0M | $120.8M |
| Total liabilities | $2.5M | $4.0M | $3.3M | $3.7M | $3.3M |
| Stockholders' equity | $122.0M | $120.4M | $119.3M | $118.3M | $117.5M |
| Cash and investments | $87.5M | $87.4M | $85.8M | $84.3M | $82.2M |
| Total debt | $195,000 | $210,000 | $286,000 | — | $256,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2026 | Jul 23, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
All 848 Utah Medical Products, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.